, Agreement between the European Community and New Zealand on sanitary measures applicable…

In forcesince 1 Apr 2015

Commodity | Disease |

Disease Attestation

Number*) Optional attestations need only be applied to the certificate when applicable.

(i)

Milk and Milk Products:

8.0 13.0

FMD |

The milk/milk products herein described:

EITHER

1*) have undergone sterilisation of at least F03.

OR

2*) have undergone an ultra-high temperature (UHT) treatment at 132 °C for at least 1 second.

OR

3*) had a pH of less than 7,0 prior to undergoing a high temperature — short time pasteurisation (HTST) treatment at 72 °C for 15 seconds.

OR

4*) had a pH of more than 7,0 prior to undergoing a double high temperature — short time pasteurisation (HTST) treatment at 72 °C for 15 seconds.

OR

5*) have been subjected to high temperature — short time pasteurisation (HTST) combined with the lowering of pH below 6 for one hour.

OR

6*) have been subjected to high temperature — short time pasteurisation (HTST) combined with additional heating to 72 °C combined with desiccation or an equivalent validated and approved drying/desiccation process that achieves at minimum an equivalent thermal effect of 72 °C for 15 seconds.

(ii)

Meat (including minced meat) and meat preparations from bi-ungulates excluding head, feet, viscera and meat from swine (suidae):

4.A 4.C 5.A 5.C

FMD |

The [insert relevant commodity] herein described (excluding feet, head and viscera) was:

1.

derived from animals that have been subjected to ante-mortem and post-mortem inspections and have been found free of any sign suggestive of FMD;

2.

derived from deboned carcasses from which the offal and major lymphatic glands have been removed;

3.

subject to maturation at a temperature above + 2 °C for at least 24 hrs and reached a pH value of below 6 when tested in the middle of the longissimus dorsi muscle after maturation and before deboning;

4.

was not derived from animals slaughtered or processed in an establishment located within a designated protection or surveillance zone,

5.

Meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.

(iii)

Meat (including minced meat) and other animal products (including offal) derived from bi-ungulates including swine (suidae):

4.A 4.C 5.A 5.C 7.A 7.B 7.C 7.D 7.E 7.F 7.G 11.E

FMD |

The [insert relevant commodity] herein described was:

I) derived from animals that have been subjected to ante-mortem and post-mortem inspection and have been found free of any sign suggestive of FMD;

AND

EITHER

2*) derived from animals slaughtered 21 days prior to the estimated date of earliest infection in the territory; and not derived from animals slaughtered or processed in an establishment located within a designated protection or surveillance zone.

OR

3*) derived from animals that have been resident on a holding for at least 21 days and were identified so as to allow the tracing of the holding of origin; but not derived from animals resident in holdings within a protection or surveillance zone; and the commodity has been clearly identified and detained under official supervision for at least 7 days and was not released until any suspicion of infection with the foot-and-mouth disease virus on the holding of origin has been officially ruled out at the end of the detention period;

AND

4.

Meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.

(iv)

Meat and meat preparations from Poultry (including turkeys):

4.B 4.C 5.B 5.C

HPNAI —

Notifiable in accordance with OIE Terrestrial Animal Health Code criteria

The [insert relevant commodity] herein described was derived from animals that:

EITHER

1*) have been sourced from a holding situated outside a protection or a surveillance zone; and all meat sourced from animals within the protection and surveillance zones is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.;

OR

2*) have been sourced from a holding within a surveillance zone but outside a protection zone and have been tested to give a 95 % probability of detecting a 5 % prevalence of HPNAI infection not more than 7 days prior to slaughter using virus detection tests, and/or serological tests, with negative results; and have been slaughtered in a designated establishment which has not processed poultry infected with HPNAI since last cleaned and disinfected, and have been subjected to ante-mortem and post-mortem examinations and have shown no signs suggestive of HPNAI; and all meat sourced from animals within the protection zone is subject to official control and has been identified and controlled so as to ensure its exclusion from this consignment.

OR

3*) were processed on a date at least 21 days before the estimated date of earliest infection.

(v)

Meat and meat preparations from Poultry (including turkeys):

4.B 4.C 5.B 5.C

LPNAI

Notifiable in accordance with OIE Terrestrial Animal Health Code criteria

The [insert relevant commodity] herein described was derived from animals that;

1.

have been sourced from a holding in which there has been no evidence of LPNAI during the past 21 days;

2.

have been slaughtered in an approved establishment which has not processed poultry infected with LPNAI since last cleaned and disinfected;

3.

have been subjected to ante-mortem and post-mortem examinations and have shown no signs suggestive of LPNAI;

(vi)

Meat and meat preparations from Poultry (including turkeys):

4.B 4.C 5.B 5.C

ND |

The [insert relevant commodity] herein described was derived from:

1.

Animals from holdings free from ND and not situated in an ND protection or surveillance zone;

AND

EITHER

2*) have not been vaccinated against ND;

OR

3*) were vaccinated against ND using a vaccine complying with the standards described in Commission Decision 93/152/EEC (the nature of the vaccine used and the date of vaccination shall also be stated in the certificate).

AND

4.

The animals showed no clinical sign of ND on the day of shipment to the slaughter house and were further subjected to ante-mortem and post-mortem examination and having showed no clinical signs suggestive of ND; were slaughtered in an approved establishment that is subject to regular inspection by the Veterinary Competent Authority and which has not processed poultry infected with ND since having last cleaned and disinfected.

(vii)

Meat Products and other processed products derived from bi-ungulates including swine (suidae) and poultry (including turkeys):

6.A 6.B 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, CSF, SVD, ASF, RND, ND, LPNAI, HPNAI, PPR | The [insert relevant commodity] herein described has been heat treated in a hermetically sealed container with an F0 value of 3,00 or more

(viii)

Meat Products and other processed products derived from bi-ungulates including swine (suidae) and poultry (including turkeys):

6.A 6.B 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, CSF, SVD, RND, ND, LPNAI, HPNAI, PPR |

EITHER

1*) The [insert relevant commodity] herein described has been heat treated to a minimum temperature of 70 °C throughout the product.

OR

2*) The [insert relevant commodity] herein described has been heat treated to 70 °C for minimum 30 minutes or an equivalent validated and approved thermal process.

(ix)

Meat Products and other processed products derived from bi-ungulates including swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, CSF, SVD, ASF, RND, PPR | The [insert relevant commodity] herein described has undergone heat treatment in a hermetically sealed container to at least 60 °C for a minimum of 4 hours, during which time the core temperature has reached at least 70 °C for 30 minutes.

(x)

Meat Products and other processed products derived from swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

ASF | The [insert relevant commodity] herein described has been heat treated to a minimum temperature of 80 °C throughout the product.

(xi)

Meat Products and other processed products (boneless) derived from bi-ungulates including swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, CSF, SVD, ASF, RND | The [insert relevant commodity] herein described is boneless and has undergone a natural fermentation and maturation process for not less than nine months resulting in the following characteristics: Aw value of not more than 0,93 or a pH value of not more than 6,0.

(xii)

Meat Products and other processed products (including bone in) derived from bi-ungulates including swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, CSF, SVD | The [insert relevant commodity] herein described which may contain bone has undergone a natural fermentation and maturation process for not less than nine months resulting in the following characteristics: Aw value of not more than 0,93 or a pH value of not more than 6,0.

(xiii)

Meat Products and other processed products derived from bi-ungulates including swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

FMD, PPR | The [insert relevant commodity] herein described has been heat treated to ensure a core temperature of at least 65 °C is reached for the time necessary to achieve a pasteurisation value (PV) equal to, or more than, 40.

(xiv)

Meat Products and other processed products derived from swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

CSF |

The [insert relevant commodity] herein described is a dry cured pork meat1 and is;

EITHER

1*) Bone-in Italian style pork ham that has been cured with salt and dried for a minimum of 313 days1;

OR

2*) Bone-in Spanish style pork, Iberian shoulder, that has been cured with salt and dried for a minimum of 252 days1;

OR

3*) Bone-in Spanish style pork, Iberian loin, that has been cured with salt and dried for a minimum of 126 days1;

OR

4*) Bone-in Spanish style pork, Serrano ham, that has been cured with salt and dried for a minimum of 140 days1.

Foot note 1: At the time of publication import conditions for pork meat into New Zealand may apply curing times exceeding the minimum stated for CSF.

(xv)

Meat Products and other processed products derived from swine (suidae):

6.A 6.C 6.D 7.B 7.C 7.D 7.E 7.F 7.G7.H

ASF | The [insert relevant commodity] herein described has been subject to treatment involving natural fermentation and maturation during at least 190 days for hams and 140 days for loins.

(xvi) Animal Casings derived from ruminants:

7.A 12.0

FMD | The animal casings herein described have been cleaned, scraped and either salted with sodium chloride for 30 days or bleached or dried after scraping and were protected from recontamination after treatment.

(xvii) Processed (rendered) Animal Protein, lards, fats and petfood derived from ungulates and poultry (including turkeys):

15.0 17.0 21.0

FMD, SVD, RND, PPR, ASF, ND, LSD | The [insert relevant commodity] herein described has been thermally treated in accordance with minimum regulatory standards and to a minimum 90 degrees Celsius for ten minutes throughout the product.

(xviii) Wool and fibre from ruminants:

20.0

FMD, RND |

EITHER

1*) The [insert relevant commodity] herein described has been stored at 18 °C for 4 weeks, or 4 °C for 4 months, or 37 °C for 8 days

OR

2*) The [insert relevant commodity] herein described has been subject to industrial scouring by immersion in water soluble detergent at 60-70 °C.

OR

3*) The unprocessed [insert relevant commodity] has been cleaned, dried and securely enclosed in packaging in accordance with the requirements of Regulation (EC) No 1069/2009

(xix) Treated Hides and Skins:

19

FMD, RND | The hides or skins herein described have been salted for 7 days in sea salt containing at least 2 % sodium carbonate.

(xx)

Treated Hides and Skins:

19

FMD |

EITHER

1*) The hides or skins herein described have been dry or wet salted for 14 days prior to dispatch and have been shipped by sea.

OR

2*) The hides and skins herein described have been dried for 42 days at temperatures of at least 20 °C.

(xxii) Fully Treated Hides and Skins (wet blue, pickled, limed or hides that have completed the tanning process):

19

FMD, RND |

Fully treated hides and skins can be traded without restriction provided that these products have been submitted to the usual chemical and mechanical processes in use in the tanning industry.

The following attestation may be applied in order to facilitate trade:

The fully treated hides and skins described have been submitted to the usual chemical and mechanical processes in use in the tanning industry.

(xxiii) Bovine Semen:

1

FMD |

The semen herein described:

EITHER

1*) was derived from donor animals which were kept in a semen collection centre where no animals have been added in last the 30 days before collection and FMD has not occurred within 10 kilometres for 30 days before and after collection, and which showed no clinical sign of FMD on the day of collection, have not been vaccinated against FMD and were subjected, not less than 21 days after collection of the semen, to a tests for antibodies against FMD virus, with negative results and no other animals present in the semen collection centre has been vaccinated against FMD. Additionally, the semen was collected from a semen collection centre not located within a protection or surveillance zone and any semen collected within a protection and surveillance zone has been clearly identified and detained under official supervision; and the semen collected, was further processed and stored in conformity with the provisions of Chapter 4.5 or Chapter 4.6 of the OIE Terrestrial Animal Health Code as relevant and was further stored in the country of origin for a period of at least one month following collection, and during this period no animal on the establishment where the donor animals were kept showed any sign of FMD.

OR

2*) has been collected and stored frozen at least 21 days before the estimated date of earliest infection with the foot-and-mouth disease virus on a holding in the protection and surveillance zone; and any semen collected after the date of earliest infection has been stored separately and was only released after all the measures relating to the outbreak of FMD have been removed; and all animals accommodated in the semen collection centre have undergone a clinical examination and samples taken have been subjected to a serological test to substantiate the absence of infection in the centre concerned; and the donor animals have been subjected with negative result to a serological test for the detection of antibodies against the FMD virus on a sample taken not earlier than 28 days after the collection of the semen.

(xxiv) Bovine Semen:

1

BT |

The semen herein described was derived from donor animals:

EITHER

That were kept in a vector-protected establishment for at least 60 days before the commencement of, and during, collection of the semen;

OR

That were subjected to a serological test according to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals to detect antibody to the BTV group, with negative results, at least every 60 days throughout the collection period and between 21 days and 60 days after the final collection for the consignment to be exported:

OR

That were subjected to an agent identification test according to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on blood samples collected at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (for PCR test) during, semen collection for the consignment to be exported, with negative results:

OR

The semen collection centre is not within an infected (restricted) zone. Semen from infected (restricted) zones has been clearly identified and detained under official supervision.

AND

The semen was collected, processed and stored in conformity with the OIE standards.

(xxv) Bovine Semen:

1

LSD |

The semen herein described was derived from donor animals:

That showed no clinical sign of LSD on the day of collection of the semen and for the following 28 days; and the animals were kept in the exporting country for the 28 days prior to collection, in a semen collection centre where no case of LSD was officially reported during that period, and the centre was not situated in either a LSD infected zone or buffer zone and any semen from buffer zone has been clearly identified and controlled.

(xxvi) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida):

2

FMD |

The in vivo derived embryos herein described were derived from donors that:

Were free of clinical signs of FMD, at the time of collection; and from which the embryos were conceived by artificial insemination using semen collected, processed and stored in semen collection centres approved by the competent authority in conformity with OIE standards. In addition the embryos have been collected, processed and stored in accordance with standards laid down by the competent authority;

AND

The donor animals from which the embryos were collected originate from a herd(s) that was/were not located within a protection or surveillance zone. Embryos collected within the protection and surveillance zones have been clearly identified and detained under official supervision.

(xxvii) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida):

2

BT |

The in vivo derived embryos herein described were derived from donors that:

Were free of clinical signs of BT at the time of collection and from which the embryos were conceived by artificial insemination using semen collected, processed and stored in semen collection centres approved by the competent authority in conformity with the OIE standards.

AND

The embryos were collected, processed and stored in accordance with standards laid down by the competent authority.

(xxviii) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida):

2

VS |

The in vivo derived embryos herein described were derived from donors that:

Were kept for 21 days prior to, and during, collection in an establishment where no case of VS was reported during that period and were subject to a diagnostic test for VS, with negative results, within 21 days prior to embryo collection. In addition the embryos were collected, processed and stored in conformity with OIE notified standards; and the establishment was not located within a protection or surveillance zone. Embryos collected within protection and surveillance zones has been clearly identified and detained under official supervision.

(xxix) In vivo derived bovine embryos (except embryos that have been subjected to penetration of the zona pellucida):

2

CBPP |

The in vivo derived embryos herein described were derived from donors that:

EITHER

1*) have not been vaccinated against CBPP and were subjected to the complement fixation test for CBPP with negative results, on two occasions, with an interval of not less than 21 days and not more than 30 days between each test, the second test being performed within 14 days prior to collection; and were isolated from other domestic bovidae from the day of the first complement fixation test until collection;

OR

2*) were vaccinated using a vaccine complying with the standards described in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals not more than 4 months prior to collection;

AND

showed no clinical sign of CBPP on the day of collection of the embryos; and were kept since birth, or for the past 6 months, in a herd(s) where no case of CBPP was reported during that period, and that the herd(s) was/were not situated in a CBPP infected zone; and the embryos were collected, processed and stored in accordance with standards laid down by the competent authority.